中国实用妇科与产科杂志

• 专题笔谈 • 上一篇    下一篇

21~24岁年轻女性子宫颈癌筛查建议及子宫颈病变的处理

  

  1. 1.北京大学第一医院妇产科宫颈诊疗中心,北京100034;2.肇庆医学高等专科学校,广东 肇庆 526040
  • 出版日期:2020-07-02 发布日期:2020-06-30
  • 通讯作者: 赵健
  • 基金资助:
    国家自然科学基金(81773533)

Recommendations for cervical cancer screening and management of cervical lesions in young women aged 21-24.

  1. Cervical Diagnosis and Treatment Center,Department of Obstetrics and Gynecology,Peking University First Hospital,Beijing 100034,China
  • Online:2020-07-02 Published:2020-06-30

摘要: 21~24岁年轻女性子宫颈癌及癌前病变发生率较低,且该年龄段子宫颈病变逆转可能性大,因此对21~24岁年轻女性初级筛查建议采用单独子宫颈脱落细胞学检测;对于子宫颈细胞学筛查结果异常推荐随访为主;异常组织病理学趋于保守处理,根据病变级别和细胞学筛查结果实施分层管理,并采取子宫颈脱落细胞学、高危型HPV检测以及阴道镜检查随访。

关键词: 子宫颈病变, 21~24岁女性, 子宫颈癌筛查, 细胞学高危异常

Abstract: The incidence of cervical cancer and precancerous lesions in 21-24-year-old young women is relatively low,and the possibility of reversion of cervical lesions is high in this age group.Therefore,it is recommended to use a separate cervical exfoliative cytology test for the primary screening of 21-24-year-old young women.For the abnormal cervical cytology screening results,follow-up check is recommended; the women with abnormal histopathology tend to be treated conservatively.According to the pathological grade and cytological screening results,the management is carried out in different levels,and cervical exfoliative cytology,high-risk HPV detection and colposcopy are used for follow-up check.

Key words: cervical lesions;women aged 21-24;cervical cancer screening;high-risk abnormal , cytology

中图分类号: